We have collected information about Drug Delivery Devices Based On Mesoporous Silica for you. Follow the links to find out details on Drug Delivery Devices Based On Mesoporous Silica.
https://www.researchgate.net/publication/8537493_Drug_Delivery_Devices_Based_on_Mesoporous_Silicate
Drug Delivery Devices Based on Mesoporous Silicate Article in Drug Delivery 11(1):41-6 · October 2008 with 29 Reads How we measure 'reads'
https://www.sciencedirect.com/science/article/pii/S1387181120301189
1. Introduction. Since their emergence in 1970, mesoporous silica nanoparticles (MSNs) have been widely used for biomedical applications, namely controlled drug/gene delivery [, , ], cell tracking [], tumor targeting [], and photodynamic therapy [6,7].MSNs have addressed several issues in regard to other nanomaterials, specifically the possible hydrolysis and enzymatic degradation of ...Author: Amirala Bakhshian Nik, Hossein Zare, Seyedsahameddin Razavi, Hesameddin Mohammadi, Pooya Torab Ahmad...
https://www.sciencedirect.com/science/article/pii/B9780128140338000114
Mesoporous Silica–Based Tetracycline Drug-Delivery Systems Tetracyclines are one of the oldest broad-spectrum antibiotics still in use ( Fig. 11.3 ). Chlortetracycline was the first member of this class discovered in the late 1940s by Benjamin Minge Duggar.Author: Raul-Augustin Mitran, Mihaela Deaconu, Cristian Matei, Daniela Berger
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943960/
Dec 25, 2017 · 1. Introduction. Mesoporous silica nanoparticles (MSNs) have revolutionized the field of controlled drug delivery systems. Their advantageous features as well-ordered internal mesopores (typically ca. 2–6 nm) with large pore volume (0.6–1 cm 3 /g) and surface area (700–1000 m 2 /g), tunable size (50–200 nm) and shape, robustness and easy surface modification, make them ideal …Author: María Vallet-Regí, Montserrat Colilla, Isabel Izquierdo-Barba, Miguel Manzano
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977336/
May 12, 2018 · One of the possibilities for improving delivery and targeting is the utilization of mesoporous silica nanoparticles (SBA-15). SBA-15 mesoporous silica has already been shown as a suitable drug delivery system for various potent antitumor compounds [25,26,27].Author: Tamara Krajnović, Danijela Maksimović-Ivanić, Sanja Mijatović, Dijana Drača, Katharina Wolf, David E...
https://pubs.acs.org/doi/10.1021/cm402592t
Oct 03, 2013 · Nanosized mesoporous silica particles with high colloidal stability attract growing attention as drug delivery systems for targeted cancer treatment and as bioimaging devices. This Perspective describes recent breakthroughs in mesoporous silica nanoparticle design to demonstrate their high potential as multifunctional drug delivery nanocarriers. These types of nanoparticles can feature a well ...Author: Christian Argyo, Veronika Weiss, Christoph Bräuchle, Thomas Bein
https://pubs.rsc.org/en/content/articlelanding/2012/cs/c2cs15308d
This review highlights the most recent research progress on silica-based controlled drug delivery systems, including: (i) pure mesoporous silica sustained-release systems, (ii) magnetism and/or luminescence functionalized mesoporous silica systems which integrate targeting and tracking abilities of drug molecules, and (iii) stimuli-responsive ...Author: Piaoping Yang, Piaoping Yang, Shili Gai, Jun Lin
https://www.researchgate.net/publication/257079648_Drug_delivery_devices_based_on_macroporous_silica_spheres
Drug delivery devices based on macroporous silica spheres. ... The amount of ibuprofen adsorbed into the nanoreservoir of TUD-1 material was higher than reported for other mesoporous silica drug ...
http://web.ics.purdue.edu/~jfleary/nanomedicine_course_2011/Lecture_5%20Core%20materials/Lecture%205%20References/Slowing_Mesoporous_NP_drug%20delivery-sensing.pdf
opment of controlled release and drug delivery devices using mesoporous silica nanomaterials, the effects of these materials on cellular development and propagation, and the difference in develop- ment between normal and cancer cells with the ultimate goal of controlling the release of antitumor
https://link.springer.com/article/10.1208%2Fs12249-014-0142-7
May 29, 2014 · Mesoporous silica nanoparticles (MSNs) have been proposed as drug delivery devices for approximately 15 years. The history of in vitro studies has been promising, demonstrating that MSNs have the capability for stimulus-responsive controlled release, good cellular uptake, cell specific targeting, and the ability to carry a variety of cargoes from hydrophobic drug molecules to imaging agents.Author: Robert Roggers, Shrey Kanvinde, Suthida Boonsith, David Oupický
Searching for Drug Delivery Devices Based On Mesoporous Silica?
You can just click the links above. The data is collected for you.
